These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 20542057)

  • 1. Cholinesterase inhibitors and stress: effects on brain muscarinic receptor density in mice.
    Mauck B; Lucot JB; Paton S; Grubbs RD
    Neurotoxicology; 2010 Sep; 31(5):461-7. PubMed ID: 20542057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of combined exposure to pyridostigmine bromide and shaker stress on acoustic startle response, pre-pulse inhibition and open field behavior in mice.
    Dubovicky M; Paton S; Morris M; Mach M; Lucot JB
    J Appl Toxicol; 2007; 27(3):276-83. PubMed ID: 17265421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stress does not enable pyridostigmine to inhibit brain cholinesterase after parenteral administration.
    Grauer E; Alkalai D; Kapon J; Cohen G; Raveh L
    Toxicol Appl Pharmacol; 2000 May; 164(3):301-4. PubMed ID: 10799340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of daily stress or repeated paraoxon exposures on subacute pyridostigmine toxicity in rats.
    Shaikh J; Karanth S; Chakraborty D; Pruett S; Pope CN
    Arch Toxicol; 2003 Oct; 77(10):576-83. PubMed ID: 14574445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gulf War illness: Effects of repeated stress and pyridostigmine treatment on blood-brain barrier permeability and cholinesterase activity in rat brain.
    Amourette C; Lamproglou I; Barbier L; Fauquette W; Zoppe A; Viret R; Diserbo M
    Behav Brain Res; 2009 Nov; 203(2):207-14. PubMed ID: 19433115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A T-cell-dependent humoral immune response is preserved during the administration of the nerve agent pre-treatment pyridostigmine bromide in a murine model.
    Griffiths GD; Telford G; Hooi DS; Cook DL; Wilkinson LJ; Green CA; Pritchard DI
    Int Immunopharmacol; 2005 Mar; 5(3):525-40. PubMed ID: 15683849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stressful manipulations that elevate corticosterone reduce blood-brain barrier permeability to pyridostigmine in the Rat.
    Sinton CM; Fitch TE; Petty F; Haley RW
    Toxicol Appl Pharmacol; 2000 May; 165(1):99-105. PubMed ID: 10814558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stress and combined exposure to low doses of pyridostigmine bromide, DEET, and permethrin produce neurochemical and neuropathological alterations in cerebral cortex, hippocampus, and cerebellum.
    Abdel-Rahman A; Abou-Donia S; El-Masry E; Shetty A; Abou-Donia M
    J Toxicol Environ Health A; 2004 Jan; 67(2):163-92. PubMed ID: 14675905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed neurologic and behavioral effects of subtoxic doses of cholinesterase inhibitors.
    Scremin OU; Shih TM; Huynh L; Roch M; Booth R; Jenden DJ
    J Pharmacol Exp Ther; 2003 Mar; 304(3):1111-9. PubMed ID: 12604688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Examination of concurrent exposure to repeated stress and chlorpyrifos on cholinergic, glutamatergic, and monoamine neurotransmitter systems in rat forebrain regions.
    Pung T; Klein B; Blodgett D; Jortner B; Ehrich M
    Int J Toxicol; 2006; 25(1):65-80. PubMed ID: 16510359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed behavioral and endocrine effects of sarin and stress exposure in mice.
    Mach M; Grubbs RD; Price WA; Nagaoka M; Dubovický M; Lucot JB
    J Appl Toxicol; 2008 Mar; 28(2):132-9. PubMed ID: 17503400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired muscarinic regulation of excitatory synaptic transmission in the APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Goto Y; Niidome T; Hongo H; Akaike A; Kihara T; Sugimoto H
    Eur J Pharmacol; 2008 Mar; 583(1):84-91. PubMed ID: 18282567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensorimotor deficit and cholinergic changes following coexposure with pyridostigmine bromide and sarin in rats.
    Abou-Donia MB; Dechkovskaia AM; Goldstein LB; Bullman SL; Khan WA
    Toxicol Sci; 2002 Mar; 66(1):148-58. PubMed ID: 11861982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acetylcholinesterase inhibition increases in vivo N-(2-[18F]fluoroethyl)-4-piperidyl benzilate binding to muscarinic acetylcholine receptors.
    Skaddan MB; Kilbourn MR; Snyder SE; Sherman PS
    J Cereb Blood Flow Metab; 2001 Feb; 21(2):144-8. PubMed ID: 11176279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of combined, multiple stressors on pyridostigmine-induced acute toxicity in rats.
    Baireddy P; Mirajkar N; Nallapaneni A; Singleton N; Pope CN
    Arch Toxicol; 2007 Apr; 81(4):283-9. PubMed ID: 16944100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioral changes after acetylcholinesterase inhibition with physostigmine in mice.
    Mach M; Grubbs RD; Price WA; Paton SJ; Lucot JB
    Pharmacol Biochem Behav; 2004 Nov; 79(3):533-40. PubMed ID: 15582025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation and blockade of cardiac muscarinic receptors by endogenous acetylcholine and cholinesterase inhibitors.
    Brown JH; Wetzel GT; Dunlap J
    J Pharmacol Exp Ther; 1982 Oct; 223(1):20-4. PubMed ID: 6288918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose cholinesterase inhibitors do not induce delayed effects on cerebral blood flow and metabolism.
    Scremin OU; Shih TM; Huynh L; Roch M; Sun W; Chialvo DR; Jenden DJ
    Pharmacol Biochem Behav; 2005 Apr; 80(4):529-40. PubMed ID: 15820522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of organophosphate exposure on muscarinic acetylcholine receptor subtype mRNA levels in the adult rat.
    Yagle K; Costa LG
    Neurotoxicology; 1996; 17(2):523-30. PubMed ID: 8856746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pituitary-adrenal responses to cholinergic stimulation and acute mild stress are differentially elevated in male and female M(2) muscarinic receptor knockout mice.
    Rhodes ME; Billings TE; Czambel RK; Rubin RT
    J Neuroendocrinol; 2005 Dec; 17(12):817-26. PubMed ID: 16280029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.